Tag: EUnetHTA

ISPOR COMMENTS ON PROPOSED EUROPEAN UNION COOPERATION ON HEALTH TECHNOLOGY ASSESSMENT

Society’s Comments Emphasize Need for Ongoing Collaboration and Observation of HTA Good Practices   Princeton, NJ—January 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has submitted comments in response to the European Commission’s request for public consultation regarding

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

ISPOR “ON THE ROAD” IN 1ST QUARTER 2016

ANNOUNCEMENT  ISPOR “ON THE ROAD” IN 1ST QUARTER 2016  Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) attended a number of industry meetings during the first quarter of 2016. The following is a sampling of ISPOR’s

Posted in Announcements Tagged with: , , , , , ,

ISPOR’s 1st PLENARY OF 18th ANNUAL EUROPEAN CONGRESS FOCUSES ON LIFECYCLE APPROACH TO DECISION MAKING ON HEALTH TECHNOLOGIES

Milan, Italy—November 9, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress first plenary session — Strategy in Motion: The Current and Future

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,

ISPOR EUROPEAN CONGRESS FOCUSES ON “IMPACTING HEALTH DECISION MAKING WITH OUTCOMES RESEARCH”

18th ANNUAL CONGRESS TO BE HELD 7-11 NOVEMBER, 2015 IN MILAN, ITALY  Princeton, NJ—November 2, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced confirmation of key scientific sessions for its 18th Annual European Congress starting next week, 7-11

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , ,

Collaboration Between Regulators And HTA Organizations To Improve Health Care Decision Making

PRINCETON, NJ, June 25, 2014 (ISPOR) — As announced today by the European network for Health Technology Assessment (EUnetHTA) and European Medicines Agency (EMA), Value in Health, the official journal for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), was pleased to publish

Posted in ISPOR News & Press, Value in Health Tagged with: , , ,

Pricing The Side Effects Of Prostate Cancer Treatment

Diemen, The Netherlands – Increased sharing of information across jurisdictions regarding the assessments of pharmaceuticals may save costs and reduce duplication of efforts.

Posted in Preference-Based Assessments, Value in Health Tagged with: , , , ,